My friend Dr. Dave Janda interviews me on his Sunday radio show. We break down the ongoing war in Gaza and the global power dynamics behind it and the chaos elsewhere in the world — a discussion you won’t hear anywhere else.
With over four decades in Washington, D.C., serving as an advisor and consultant to four administrations, Dr. Janda brings unmatched insight and experience.
If you are not following his work, you should be. You can find him at DaveJanda.com
OCTOBER PEPTIDE SALE IS STILL ON! Many favorite peptides are on sale, find them all here: October Sale
Included in the sale is Tesofensine! one of the peptides I recommend in the “Ultimate Peptide Guide for Weight Loss and Muscle Preservation”
What you save: 15% plus another 15% using code Sarah
Link to Buy: Tesofensine
What does the research say about Tesofensine?
Tesofensine is a triple reuptake inhibitor that affects dopamine, serotonin, and noradrenaline neurotransmitters. It was initially developed by NeuroSearch for the treatment of Alzheimer’s and Parkinson’s diseases. Interestingly, during the development process, significant weight loss was observed among the participants, leading to a shift in the focus of tesofensine research towards obesity treatment.
In clinical trials, tesofensine has shown promising results in inducing weight loss, primarily by suppressing appetite and increasing energy metabolism. It has been found to potentially produce a weight loss twice that of currently approved drugs. Moreover, it has been studied for its potential effects on alcohol addiction, arousal disorder symptoms, and respiratory diseases such as chronic obstructive pulmonary disease (COPD) [R].
Tesofensine is currently in phase III trials for obesity treatment. The future of tesofensine research looks promising, with potential applications in various medical conditions beyond obesity.
**Findings:** Out of the total participants, 161 (79%) successfully completed the study. At the 24-week mark, participants following a diet with a placebo showed an average weight loss of 2.0% (SE 0.60). In comparison, those administered tesofensine in doses of 0.25 mg, 0.5 mg, and 1.0 mg alongside their diet experienced mean weight losses of 4.5% (SE 0.87), 9.2% (SE 0.91), and 10.6% (SE 0.84) respectively, all significantly higher than the diet and placebo group (p<0.0001).
Link to Buy: Tesofensine
Be sure to sign up for their newsletter and watch for upcoming sales. Periodically your favorites will make it to a sale.
Please take a moment to rate and review my podcast on Apple Podcasts.
I’m competing against the biggest names — and the deepest pockets — in media, yet I’m still holding a Top 20 spot in Business News, nearly 8 years running.
Apple is the one major platform that didn’t canceled me, but the competition is becoming more fierce.
Your review helps me stay visible, relevant, and independent.
